Finch Therapeutics Announces Clinical Collaboration In Ulcerative Colitis With Brigham And Women’s Hospital And Updates To University Of Minnesota License Agreement
Finch Therapeutics Group, Inc. ("Finch", "Finch Therapeutics" or the "Company") (NASDAQ:FNCH), a microbiome technology company with a portfolio of intellectual property and microbiome